40.12
21.23%
+7.025
Dopo l'orario di chiusura:
40.0856
-0.0344
-0.09%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PTCT Giù?
Forum
Previsione
PTC Therapeutics Inc Azioni (PTCT) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
56.20%
307.06
|
196.58 | 213.81 | 220.38 | 167.41 |
Operating Expenses
|
4.29%
301.24
|
314.74 | 423.35 | 338.00 | 367.75 |
Benefits Costs and Expenses |
27.79%
464.11
|
363.17 | 451.29 | 355.37 | 357.11 |
Costs And Expenses |
27.79%
464.11
|
363.17 | 451.29 | 355.37 | 357.11 |
Operating Income/Loss |
104.93%
5.82
|
-118.16 | -209.54 | -117.61 | -200.34 |
Income/Loss From Continuing Operations Before Tax |
5.73%
-157.05
|
-166.59 | -237.48 | -134.99 | -189.69 |
Income Tax Expense/Benefit, Deferred |
199.05K%
3.979
|
-0.002 | -50.90 | -0.004 | - |
Income Tax Expense/Benefit |
96.26%
-1.259
|
-33.62 | -38.60 | 3.969 | -18.80 |
Income/Loss From Continuing Operations After Tax |
17.16%
-155.79
|
-132.97 | -198.88 | -138.96 | -170.89 |
Net Income/Loss
|
17.16%
-155.79
|
-132.97 | -198.88 | -138.96 | -170.89 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.71%
0.2198
|
75.38 | 74.73 | 73.73 | 0.3128 |
Diluted Average Shares |
99.71%
0.2198
|
75.38 | 74.73 | 73.73 | 0.3128 |
Basic Earnings Per Share |
17.05%
-2.06
|
-1.76 | -2.66 | -1.88 | -2.36 |
Diluted Earnings Per Share |
17.05%
-2.06
|
-1.76 | -2.66 | -1.88 | -2.36 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):